Benzylamine Market Intelligence Report (May 2026)

I. Price Trends
1. Current Mainstream Price Range
– Domestic benzylamine (purity ≥99%) is priced stably at RMB 25,000 per metric ton. Quotations from major producers—including Shandong Aite Chemical Co., Ltd. and Changzhou Aozun Composite New Materials Co., Ltd.—have remained unchanged for multiple consecutive days.
– In the small-batch spot market, aggressive price competition exists: Wuhan Xinxin Jiali Biotechnology Co., Ltd. offers quotations as low as RMB 1,000 per metric ton (minimum order quantity: 1 ton); however, specifications and intended applications remain unclear—these may represent lower-purity grades or by-product streams.
– High-purity specialty products—e.g., (R)-(+)-α-methylbenzylamine (purity 99%)—command substantial premiums; Shandong Yuxuan Chemical’s February 2026 quotation reached RMB 80,000 per metric ton.

2. Historical Price Volatility Review
– Prices in 2025 followed a “decline-then-recovery” pattern: starting the year at approximately RMB 38,500/ton, declining to RMB 34,200/ton mid-year due to expanded capacity and intensified competition, then rebounding to RMB 41,800/ton by year-end amid rising demand for high-purity grades and import constraints on key raw materials.
– In early 2026, price volatility narrowed significantly; mainstream quotations stabilized between RMB 40,000–42,000/ton in early February, and have since remained at relatively low levels through April–May 2026, reflecting balanced supply-demand conditions.

II. Supply-Demand Landscape
1. Supply Side
– Capacity Distribution: Over 70% of China’s benzylamine production capacity is concentrated in the East China region (Jiangsu and Zhejiang provinces), forming an industrial cluster centered around Yangtze River Pharmaceutical Group, Zhejiang Yongtai Technology Co., Ltd., and Jiangsu Zhongdan Group. As of end-2025, national effective annual capacity stood at 12,500 metric tons—a 52.4% increase compared to 2021.
– Technological Upgrading: Hydrogenation-reduction processes have largely replaced traditional aluminum-amalgam methods; clean production technologies accounted for over 75% of total output in 2025. Adoption of continuous-flow microreactor synthesis has risen to 65%, reducing unit production costs by 28%.
– Environmental Compliance Pressure: The newly revised “Emission Standards for Pollutants from the Chemical Raw Materials Industry” tightened COD limits for benzylamine production wastewater to 80 mg/L, doubling average environmental operating costs per ton to over RMB 2,600—and accelerating the phase-out of outdated capacity.
– Regional Competition: The Yangtze River Delta region—anchored by Shanghai Hileap Pharma and Zhejiang Newhope Chemical—accounts for 58% of national capacity. A new 200,000-ton/year benzylamine production base in Lianyungang is currently undergoing equipment commissioning, potentially intensifying regional competition.

2. Demand Side
– Downstream Applications:
Agrochemicals: ~40% share; used in synthesizing high-efficiency, low-toxicity pesticides such as benzylamine benzoate. Global demand is projected to reach 500,000 metric tons in 2025.
Pharmaceuticals: ~32% share; employed in manufacturing antibiotics (e.g., cefixime) and anticancer agents. Its share is expected to rise to ~40% by 2030; pricing for pharmaceutical-grade products is anticipated to shift upward by 8–10%.
Fragrances: Used to synthesize benzyl benzoate and benzyl alcohol; the global flavor & fragrance market is projected to expand from USD 18 billion in 2018 to USD 30 billion in 2025.
– Demand Elasticity: Premiums for ultra-high-purity grades (≥99.5%) range from 12–15%, signaling a structural market shift toward quality-driven value creation; customized synthesis services are increasingly enabling differentiated pricing strategies.

III. Market Structure and Competition
1. High-End Segment: Leading enterprises—including Zhejiang Yongtai and Jiangsu Zhongdan—leverage electronic-grade mass-production capabilities, vertically integrated feedstock supply chains, and internationally recognized certifications to achieve gross margins exceeding 43%, commanding dominant market positions.
2. Mid-Low Tier Segment: Low-value, high-barrier manufacturers rely heavily on localized environmental infrastructure support to maintain viability—but face progressive marginalization; low-value, low-barrier small-scale producers are exiting the market at an accelerating pace.
3. Substitution Pressure: Novel fluorinated building blocks are challenging traditional benzylamine-based synthetic routes—particularly in pharmaceutical intermediates.
4. Trade Barriers: Tightening regulatory requirements—including EU REACH, U.S. EPA regulations, and the potential implementation of the EU Carbon Border Adjustment Mechanism (CBAM)—are compelling domestic producers to expedite green process upgrades.

IV. Forward Outlook (2026–2030)
1. Price Trend
– Short Term (2026): Stable supply-demand equilibrium will sustain low-price conditions; mainstream quotations are expected to remain within RMB 25,000–26,000/ton.
– Medium–Long Term (2027–2030): Rising demand for high-purity products and escalating environmental compliance costs will gradually lift the overall price center; pharmaceutical-grade premium rates are expected to widen further.

2. Supply-Demand Evolution
– Supply Side: Capacity consolidation in East China will continue; commissioning of the Lianyungang mega-base may exacerbate regional oversupply pressure; environmental regulation will accelerate consolidation, raising industry concentration (CR5 projected to increase from 45% to >65%).
– Demand Side: Steady growth in agrochemical and pharmaceutical applications, coupled with expansion in fragrance markets, will drive incremental demand; higher-purity product penetration will grow, making customized synthesis services a critical competitive differentiator.

3. Technological Trajectory
– Wider adoption of green synthesis technologies—including catalytic hydrogenation and continuous-flow microreactors—will further reduce unit production costs.
– Accelerated exploration of novel biocatalytic (enzyme-based) approaches will support the industry’s low-carbon transition.

4. Key Risk Factors
– Volatility in import dependency for key raw materials (e.g., benzyl chloride).
– Disruptive technological breakthroughs in alternative synthetic platforms threatening existing market share.